Thomas Vandervort

Thomas Vandervort has extensive work experience in the pharmaceutical and healthcare industry. Thomas started their career in 2010 as the Director of Business Development at West-Ward Pharmaceuticals and later worked as the Vice President of Sales at Centric Health Resources from 2012 to 2013. In 2014, they served as the Director of Business Development at IGI Laboratories, Inc., and then moved on to be the Vice President of Business Development at Teligent, Inc. from 2014 to 2015. Thomas Vandervort also served as a Board Member at Orphic Therapeutics in 2014.

In subsequent years, they held various director roles at Eyevance Pharmaceuticals, Amber Ophthalmics, Ellie Diagnostics, and AtomVie Global Radiopharma Inc., starting from 2017, 2020, 2021, and 2022 respectively. Most recently, they are a Managing Partner at Avego Management since December 2015.

Thomas Vandervort completed their education with a Master's degree in English from Duquesne University, which they obtained from 2000 to 2002. Prior to that, they also earned a Bachelor's degree in English from Bethany College, where they studied from 1996 to 2000. There is no available information regarding their education before attending Bethany College, as well as after obtaining their Master's degree. However, it is known that they attended Oldham County High School and Oldham County Middle School, but no specific degree or field of study is provided. Lastly, they also attended Regent's College, but no details regarding degree or field of study are mentioned.